marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Galera Therapeutics Financial Ratios 2011-2024 | GRTX
Annual Financial Ratios Galera Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.9 | -0.9 | -3.8 | -6.6 | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.3 | -2.3 | -3.1 | -3.0 | -16.3 | -98.4 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
147 M | 202 M | 194 M | 342 M | 380 M | 178 M | 95 M | - | - | - | - | - | - |
EBITDA per Share |
-0.9 | -1.79 | -2.74 | -2.82 | -2.03 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-2.4 | -3.8 | -6.5 | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.15 | -0.13 | - | - | - | - | - | - | - | - | ||
P/B |
-0.1 | -0.5 | -1.2 | 45.7 | 5.0 | - | - | - | - | - | - | - | - |
P/CF |
-0.2 | -1.2 | -1.1 | -4.7 | -7.3 | - | - | - | - | - | - | - | - |
ROE % |
45.04 | 56.99 | 138.84 | -1213.11 | -74.60 | - | - | - | - | - | - | - | - |
ROA % |
-226.01 | -141.30 | -96.67 | -88.25 | -42.09 | - | - | - | - | - | - | - | - |
ROCE % |
37.55 | 46.92 | 126.49 | -100.60 | -44.59 | - | - | - | - | - | - | - | - |
Current Ratio |
0.2 | 0.3 | 0.6 | 5.6 | 12.1 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Galera Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.07 | -0.08 | - | -0.33 | -0.48 | -0.5 | - | -0.6 | -0.54 | -0.58 | - | -0.86 | -0.88 | -0.75 | - | -0.69 | -0.75 | -0.74 | - | -51.43 | -45.3 | -41.12 | - | -22.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.08 | - | - | - | -0.39 | - | -0.48 | -0.44 | -0.49 | - | -0.76 | -0.82 | -0.7 | - | -0.64 | -0.71 | -0.71 | - | -42.1 | -37.1 | -34.4 | - | -17.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
30.02 | 45.08 | 48.06 | 64.51 | 69.04 | 68.52 | 55.85 | 108.26 | 144.23 | 214.47 | 317.15 | 38.01 | -293.55 | -686.23 | -885.13 | -904.31 | -644.34 | -355.99 | -50.65 | -45.64 | -21.46 | 0.07 | 16.63 | 16.63 | 11.62 | 6.70 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-126.90 | -144.99 | -112.46 | -144.07 | -135.79 | -116.72 | -77.17 | -100.08 | -91.37 | -86.96 | -68.88 | -89.19 | -86.59 | -89.35 | -64.39 | -75.21 | -65.73 | -52.91 | -28.58 | -34.54 | -29.68 | -20.31 | -5.96 | -5.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
27.62 | 39.18 | 39.42 | 52.71 | 55.42 | 55.13 | 46.29 | 93.31 | 127.05 | 195.36 | 295.01 | 32.21 | -277.62 | -649.78 | -843.56 | -862.03 | -617.70 | -344.37 | -49.60 | -44.44 | -20.81 | -4.62 | 5.16 | 5.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 2.3 | 2.3 | 2.3 | 2.3 | 3.3 | 3.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency